APA (7th ed.) Citation

Oxombre, B., Madouri, F., Journé, A., Ravez, S., Woitrain, E., Odou, P., . . . Melnyk, P. (2022). Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis. International Journal of Molecular Sciences, 23(19), 11893. https://doi.org/10.3390/ijms231911893

Chicago Style (17th ed.) Citation

Oxombre, Bénédicte, et al. "Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis." International Journal of Molecular Sciences 23, no. 19 (2022): 11893. https://doi.org/10.3390/ijms231911893.

MLA (9th ed.) Citation

Oxombre, Bénédicte, et al. "Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis." International Journal of Molecular Sciences, vol. 23, no. 19, 2022, p. 11893, https://doi.org/10.3390/ijms231911893.